The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations.
暂无分享,去创建一个
D. Tenen | J. Hsieh | S. Menéndez | S. Nimer | Motomi Osato | Xiaomei Yan | Yan Liu | Yue Zhang | Xinyang Zhao | Lan Wang | G. Sashida | Xinghui Zhao | Gang Huang | Puqing Zhang | Shannon E Elf | Youyang Yang | Hao-peng Xu | J. Lee
[1] A. Gewirtz,et al. c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis. , 2010, The Journal of clinical investigation.
[2] S. Nimer,et al. Post-translational modifications of Runx1 regulate its activity in the cell. , 2009, Blood cells, molecules & diseases.
[3] R. Roeder,et al. A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4 , 2009, Proceedings of the National Academy of Sciences.
[4] C. Allis,et al. PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks. , 2008, Mutation research.
[5] Akihiko Yokoyama,et al. Menin critically links MLL proteins with LEDGF on cancer-associated target genes. , 2008, Cancer cell.
[6] R. Ono,et al. AML1 mutations induced MDS and MDS/AML in a mouse BMT model. , 2008, Blood.
[7] C. Allis,et al. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. , 2008, Genes & development.
[8] H. Yoshida,et al. Chromatin regulation by AML1 complex , 2008, International journal of hematology.
[9] Yoshiaki Ito. RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. , 2008, Advances in cancer research.
[10] Y. Okuno,et al. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis , 2008, Nature Genetics.
[11] Ruedi Aebersold,et al. Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus. , 2007, Molecular cell.
[12] Winship Herr,et al. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. , 2007, Molecular cell.
[13] Aarthi Narayanan,et al. The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection , 2007, Proceedings of the National Academy of Sciences.
[14] Daniel Chourrout,et al. Genome Regulation by Polycomb and Trithorax Proteins , 2007, Cell.
[15] Patrick R. Cushing,et al. Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant‐negative, or hypomorphic alleles , 2007, The EMBO journal.
[16] C. Allis,et al. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. , 2007, Molecular cell.
[17] M. Cleary,et al. RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription , 2006, Oncogene.
[18] J. Rowley,et al. Chromatin structural elements and chromosomal translocations in leukemia. , 2006, DNA repair.
[19] P. Aplan,et al. Chromosomal translocations involving the MLL gene: molecular mechanisms. , 2006, DNA repair.
[20] A. Shilatifard,et al. A COMPASS in the voyage of defining the role of trithorax/MLL‐containing complexes: Linking leukemogensis to covalent modifications of chromatin , 2005, Journal of cellular biochemistry.
[21] M. Andersen,et al. Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation. , 2004, Blood.
[22] W. Herr,et al. Leukemia Proto-Oncoprotein MLL Forms a SET1-Like Histone Methyltransferase Complex with Menin To Regulate Hox Gene Expression , 2004, Molecular and Cellular Biology.
[23] Motomi Osato. Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia , 2004, Oncogene.
[24] T. Kyo,et al. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. , 2004, Blood.
[25] S. Korsmeyer,et al. Definitive hematopoiesis requires the mixed-lineage leukemia gene. , 2004, Developmental cell.
[26] Y. Hayashi,et al. AML1/RUNX1 mutations are infrequent, but related to AML‐M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies , 2003, Genes, chromosomes & cancer.
[27] G. Nucifora,et al. SUV39H1 interacts with AML1 and abrogates AML1 transactivity. AML1 is methylated in vivo , 2003, Oncogene.
[28] Daniel G. Tenen,et al. Disruption of differentiation in human cancer: AML shows the way , 2003, Nature Reviews Cancer.
[29] T. Inaba,et al. Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia. , 2003, Blood.
[30] C. Preudhomme,et al. New mechanisms of AML1 gene alteration in hematological malignancies , 2003, Leukemia.
[31] Thomas A Milne,et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. , 2002, Molecular cell.
[32] S. Mundlos,et al. Mutations in the RUNX2 gene in patients with cleidocranial dysplasia , 2002, Human mutation.
[33] Yoshiaki Ito,et al. Dimerization with PEBP2β protects RUNX1/AML1 from ubiquitin–proteasome‐mediated degradation , 2001, The EMBO journal.
[34] R. D. Hanson,et al. Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[35] H. Yamasaki,et al. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. , 1999, Blood.
[36] R. D. Hanson,et al. MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[37] T. Komori,et al. Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice. , 1998, Blood.
[38] A T Look,et al. Oncogenic transcription factors in the human acute leukemias. , 1997, Science.
[39] S. Korsmeyer,et al. Defects in yolk sac hematopoiesis in Mll-null embryos. , 1997, Blood.
[40] Y. Kanno,et al. A novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells , 1997, Molecular and cellular biology.
[41] J. Zhang,et al. AML1A and AML1B can transactivate the human IL-3 promoter. , 1997, Journal of immunology.
[42] F. Alt,et al. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. , 1996, Cell.
[43] F. Alt,et al. The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo , 1996, Cell.
[44] J. Downing,et al. AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.
[45] S. Korsmeyer,et al. Altered Hox expression and segmental identity in Mll-mutant mice , 1995, Nature.
[46] J. Rowley,et al. Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[47] H. Alder,et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene , 1992, Cell.
[48] Michael L. Cleary,et al. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias , 1992, Cell.